ArticleJournal of ovarian research2025

Interference with CHD1L inhibits the malignant progression and enhances cisplatin sensitivity of ovarian cancer cells by binding PLK1.

Kun Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.